Search the Newsreel

Vitesse Energy (VTS) Stock Faces Hedge Gain Questions After Profit Rebound

Vitesse Energy (VTS) reported a rebound to profitability in Q2, with net income of US$33 million, largely driven by unrealized hedge gains rather than operational performance. While the company's dividend yield and price-to-sales multiple appear attractive, market skepticism remains due to the quality of …

Does Revvity’s Q2 Beat, Higher Guidance and China Exit Alter the Bull Case for RVTY?

Revvity, Inc. reported past second-quarter 2026 results with sales of US$729.69 million, net income of US$51.82 million and diluted EPS from continuing operations of US$0.48, while also reaffirming a regular US$0.07 per-share quarterly dividend and issuing full-year 2026 revenue guidance of US$2.83 billion to …

Revvity Inc. Lifts Guidance After Strong Earnings

Revvity Inc. reported strong Q2 earnings, exceeding revenue and EPS guidance, leading to raised full-year targets. The Diagnostics segment and high-content screening orders were key growth drivers, while software revenue experienced volatility. The company also demonstrated strong cash flow, deleveraging progress, and an accelerated …

DaVita (DVA) Earnings Put Its Valuation Back In Focus

Why Revvity (RVTY) Stock Is Up Today

Shares of Revvity (NYSE:RVTY) jumped 3.1% after the life sciences company reported strong second-quarter 2026 results that exceeded Wall Street expectations and raised its full-year guidance. The company announced adjusted EPS of $1.41 on revenue of $729.68 million, driven by 11% organic growth in …

DaVita Stock Down in Pre-Market Despite Q2 Earnings Beat, Margins Down

DaVita (DVA) reported adjusted earnings of $4.02 per share in Q2 2026, surpassing the Zacks Consensus Estimate, with revenues of $3.55 billion also exceeding expectations. Despite beating earnings and revenue forecasts and seeing an increase in U.S. dialysis treatments, the company's stock fell in …

Analysts Offer Insights on Energy Companies: Cameco (CCJ), Vitesse Energy, Inc. (VTS) and Pembina Pipeline (PBA)

This article highlights bullish analyst sentiments for three energy companies: Cameco (CCJ), Vitesse Energy, Inc. (VTS), and Pembina Pipeline (PBA). Analysts from Stifel Nicolaus, Alliance Global Partners, and TD Cowen maintained "Buy" ratings for these respective companies, indicating potential upside from current stock levels. …

DaVita Inc. stock underperforms Wednesday when compared to competitors

Shares of DaVita Inc. (DVA) plunged 17.24% on Wednesday, closing at $188.69. This underperformance occurred during a mixed trading session where the Dow Jones Industrial Average rose, but the S&P 500 Index fell. The stock experienced its third consecutive day of losses.

Stifel raises Revvity stock price target to $110 on earnings beat

Stifel increased its price target for Revvity Inc (NYSE:RVTY) shares to $110 from $100, maintaining a Hold rating after the company reported strong Q2 2026 earnings that exceeded expectations. The beat was partly due to tariff refunds and tax savings, but also organic growth …

Barclays Adjusts Price Target on DaVita to $224 From $218

Barclays has increased its price target for DaVita Inc. (DVA) to $224 from $218. This adjustment follows other analyst updates, with BofA raising its target to $170 and Deutsche Bank to $265, reflecting varied outlooks on the healthcare facilities and services provider. The article …

Cleaner Water, Reduced Emissions Feature in Ingevity Report

Ingevity Corporation has released its 2025 Sustainability Report, "A Decade of Performance, a Future of Possibility," highlighting how its advanced materials and technologies contribute to environmental goals such as reduced emissions, extended infrastructure life, cleaner water, and the use of renewable raw materials. The …

DVA Q2 Earnings Call Centers on Clinical-Led Volume Growth

DaVita Inc. DVA used its second-quarter 2026 earnings call to emphasize improving mortality, stronger treatment volumes and expanded middle molecule clearance. Management kept its outlook intact while acknowledging commercial-mix and reimbursement pressure. Reported earnings of $4.02 per share topped the Zacks Consensus Estimate of …

Barclays Adjusts Price Target on Revvity to $115 From $105, Maintains Equalweight Rating

Barclays has increased its price target for Revvity (RVTY) shares to $115 from $105, while maintaining an Equalweight rating on the stock. This adjustment reflects an updated outlook from the analyst firm. The article also briefly mentions other analysts like Bernstein, Evercore ISI, and …

Insiders Could Have Profited By Holding onto Vital Farms Shares Despite 11% Drop

Vital Farms (NASDAQ:VITL) has seen its stock drop by 11% recently. Insiders who sold US$18 million worth of shares over the past year at an average price of US$50.78 would have been better off holding, as the current share price is US$12.15. Despite this, …

Bronstein, Gewirtz & Grossman, LLC Encourages Vital Farms, Inc. (VITL) Stockholders to Inquire about Securities Investigation

Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against Vital Farms, Inc. (NASDAQ:VITL) regarding alleged corporate wrongdoing. The firm encourages investors who purchased Vital Farms securities before May 8, 2025, and still hold them, to contact them for more information and to assist …

Beyond the Clinical: How Social Workers Drive Kidney Transplant Success

NORTHAMPTON, MA / ACCESS Newswire / August 5, 2026 / While kidney transplant is the optimal treatment path for end stage kidney disease (ESKD), complex logistical, financial and educational barriers can often stand in the way for many patients interested in pursuing it.NORTHAMPTON, MA …

Revvity posts solid Q2 2026 earnings growth

DaVita Inc. Stock 12‑Month Price Target Raised to $230, Implies 1% Upside

Analysts have raised the 12-month average price target for DaVita Inc. (DVA) stock from $217.33 to $230, with individual forecasts ranging from $170 to $270 per share. This new target suggests a 1% potential upside based on the stock's closing price on August 4. …

Vitesse Energy Tightens 2026 Outlook After Strong Quarter

Vitesse Energy reported strong second-quarter 2026 results with a net income of $33.1 million and average production up 9% sequentially. The company reinforced its shareholder-return strategy by maintaining its fixed dividend and tightened its 2026 guidance, slightly narrowing production and oil mix ranges while …

Evercore ISI Adjusts Price Target on Revvity to $126 From $125, Maintains Outperform Rating

Evercore ISI has increased its price target for Revvity (RVTY) to $126 from $125, while reaffirming its "Outperform" rating on the stock. This adjustment reflects continued positive sentiment from the analyst firm regarding Revvity's financial prospects and market position. The update follows recent financial …

Ingevity Releases 2025 Sustainability Report, Highlights Performance and Impact

Ingevity Corporation has released its 2025 Sustainability Report, titled "A Decade of Performance, a Future of Possibility," which details how its advanced materials and technologies help customers achieve environmental goals. The report highlights the company's commitment to sustainability through products that reduce emissions, extend …

Revvity Inc reports results for the quarter ended June 30 - Earnings Summary

Revvity Inc has released its earnings summary for the quarter that ended on June 30. The article, provided by Refinitiv and distributed through TradingView, is an earnings report. Full access to the complete article and other news sources is available through a TradingView subscription.

Revvity (RVTY) Stock Premium Faces Pressure From Thin Margins

Revvity (RVTY) stock experienced a 3% dip despite exceeding Q2 earnings expectations, raising concerns about its high P/E ratio of 52.4x and recent squeeze in net profit margin to 8.2%. The article explores both the bullish arguments, such as organic growth in diagnostics and …

DaVita Inc (DVA) (Q2 2026) Earnings Call Highlights: Strong Volume Growth and Strategic ...

DaVita Inc. reported strong Q2 2026 results with adjusted operating income of $579 million and EPS of $4.02, driven by higher-than-expected treatment volume growth. The company reaffirmed its full-year guidance and continued share repurchases. While facing headwinds like declining revenue per treatment due to …

Amundi Sells 32,858 Shares of Revvity Inc. $RVTY

Savita Oil Technologies reports record Q1FY27 revenue of ₹1,512.7 crore

DaVita (DVA) Stock Price Faces Margin Doubts After 17% Sell Off

Vital Farms (VITL) Reports Q2: Everything You Need To Know Ahead Of Earnings

Vital Farms (VITL), an egg and butter company, is scheduled to report its Q2 earnings this Thursday morning. The market anticipates a 10.8% year-on-year revenue decline, a reversal from the previous year's increase, and analysts have largely maintained their estimates. Despite Vital Farms' stock …

Ingevity (NYSE: NGVT) legal chief Ryan Fisher sells 2,709 shares

Ingevity's SVP, General Counsel & Secretary, Ryan C. Fisher, sold a total of 2,709 shares of company common stock on August 3, 2026. The sales were conducted in two separate open market transactions at prices of $73.76 and $73.67 per share, totaling approximately $200,000. …

DaVita Expands Access to Advanced Middle Molecule Clearance

DaVita is rapidly scaling access to advanced middle molecule clearance therapies like Expanded Hemodialysis (Expanded HD) and continuing hemodiafiltration (HDF) pilots to improve kidney care outcomes. This expansion is driven by the recent FDA approval of Nipro’s ELISIO-HX dialyzer, which allows for greater removal …

DaVita Inc. 2026: Revenue $3.55B, EPS $4.02— 10-Q Summary

DaVita Inc. reported strong financial results for the quarter ended 2026, with revenue reaching $3.55 billion and diluted EPS at $4.02, marking significant increases over the prior-year quarter. The growth was primarily driven by higher U.S. dialysis volumes and a substantial increase in ancillary …

DaVita's Profit Growth Prospects Boosted by Share Repurchases

DaVita's profit growth is expected to improve due to share repurchases, despite recent challenges from COVID-related mortality and labor pressures. The company, which specializes in services for end-stage renal disease patients, has a large network of dialysis clinics in the US and is expanding …

Is Vita Coco Company (COCO) Cheap After Strong Q2 And First Half 2026 Results?

How Investors May Respond To TE Connectivity (TEL) Earnings Beat And Completion Of Long-Term Buyback

TE Connectivity (TEL) reported higher sales and net income in its past quarter and completed a long-running share repurchase program. This combination of stronger earnings per share and a reduced share count highlights the company's profit growth paired with sustained capital returns. The article …

Does Vita Coco (COCO) Have the Earnings Power to Justify Its Premium Valuation Narrative?

[DVA Q2 2026 Earnings Call] DaVita to Roll Out Expanded Dialyzers Across Network, Lifts Volume Target to 50-75 Basis Points

DaVita reported Q2 2026 adjusted operating income of $579 million and adjusted EPS of $4.02, meeting expectations, with treatment volume growth accelerating to 56 basis points due to improved mortality. The company announced plans to broadly deploy newly FDA-approved expanded hemodialysis dialyzers following a …